The National Institutes of Health is launching the first integrated, drug development pipeline to produce new treatments for rare and neglected diseases. The $24 million program jumpstarts a trans-NIH initiative called the Therapeutics for Rare and Neglected Diseases program, or TRND.

released on May 20, 2009

Click here to read the full article.

Leave a Reply

Your email address will not be published. Required fields are marked *